Following Tessera Therapeutics?
Get the free weekly product launch digest
The latest product launches, like Tessera Therapeutics’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New product launches, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Launch Trends
See who's moving and how much in your market
No credit card required Weekly product launch digest
Tessera Therapeutics Showcases Innovative Gene Writing Data at ESGCT Congress in Rome
Oct 24, 2024•over 1 year ago
Product Description
Tessera Therapeutics presents new preclinical data on its Gene Writing™ technology for treating AATD and SCD at the European Society of Gene and Cell Therapy Congress. The company demonstrates significant advances in rewriting efficiencies and safety evaluation methods for its genetic medicine programs.